Results 11 to 20 of about 586,644 (327)

Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences. [PDF]

open access: goldBMC Health Serv Res, 2014
BackgroundThis paper examines the Willingness to Pay (WTP) for a quality-adjusted life year (QALY) expressed by people who attended the healthcare system as well as the association of attitude towards risk and other personal characteristics with their ...
Martín-Fernández J   +6 more
europepmc   +4 more sources

Cost per QALY (quality-adjusted life year) and lifetime cost of prolonged mechanical ventilation in Taiwan. [PDF]

open access: goldPLoS One, 2012
Introduction Patients who require prolonged mechanical ventilation (PMV) are increasing and producing financial burdens worldwide. This study determines the cost per QALY (quality-adjusted life year), out-of-pocket expenses, and lifetime costs for PMV ...
Hung MC   +6 more
europepmc   +4 more sources

Consistent valuation of a reduction in mortality risk using values per life, life year, and quality-adjusted life year.

open access: greenHealth Economics, 2023
The monetary value of a reduction in mortality risk can be accurately characterized using the alternative concepts of value per statistical life (VSL), value per statistical life year (VSLY), and value per quality-adjusted life year (VQALY).
J. Hammitt
semanticscholar   +3 more sources

Estimating utility weights and quality-adjusted life year loss for colorectal cancer-related health states in Korea. [PDF]

open access: yesSci Rep, 2017
We aimed to assess utility weight of health states associated with colorectal cancer (CRC) that reflect the societal preference of the Korean population and to estimate the quality-adjusted life year (QALY) loss with CRC.
Lee JY   +7 more
europepmc   +2 more sources

A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold? [PDF]

open access: yesPLoS One, 2015
Background A number of studies have been conducted to estimate willingness to pay (WTP) per quality-adjusted life years (QALY) in patients or general population for various diseases.
Nimdet K   +3 more
europepmc   +2 more sources

Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand. [PDF]

open access: yesBMJ Open, 2015
Objective To estimate the willingness to pay (WTP) per quality-adjusted life year (QALY) value for life-saving treatments and to determine factors affecting the WTP per QALY value. Design A cross-sectional survey with multistage sampling and face-to-face
Nimdet K, Ngorsuraches S.
europepmc   +2 more sources

Willingness to Pay for a Quality-Adjusted Life-Year: The Individual Perspective [PDF]

open access: yesValue in Health, 2010
The aim of this study was to elicit the individual willingness to pay (WTP) for a quality-adjusted life-year (QALY).In a Web-based questionnaire containing contingent valuation exercises, respondents valued health changes in five scenarios. In each scenario, the respondents first valued two health states on a visual analog scale (VAS) and expressed ...
Ana Bobinac   +3 more
openaire   +5 more sources

Quality-adjusted life year weights and treatment bias: Theory and evidence from cognitive interviews [PDF]

open access: yesSAGE Open Medicine, 2019
Objectives: The purpose of this research is to understand the thought processes that underpin responses to stated preference approaches for eliciting quality of life, in particular the standard gamble.
Bryan N Patenaude, Till Bärnighausen
doaj   +2 more sources

Clinimetrics: The quality adjusted life year

open access: yesJournal of Physiotherapy, 2023
Sheraya De Silva, Alisa M Higgins
openaire   +3 more sources

Estimated Quality-Adjusted Life-Year Associated with the Degree of Activities of Daily Living in Patients with Alzheimer's Disease [PDF]

open access: yesDementia and Geriatric Cognitive Disorders Extra, 2013
Background/Aims: The quality-adjusted life-year (QALY) and health state utility values (HSUVs) are major quality of life scales that are used for the analyses of health economics of diseases such as Alzheimer's disease (AD).
Mari Kasai, Kenichi Meguro
doaj   +2 more sources

Home - About - Disclaimer - Privacy